STAGE IIIB GASTRIC CANCER AJCC V7
Clinical trials for STAGE IIIB GASTRIC CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB GASTRIC CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIB GASTRIC CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise for Hard-to-Treat stomach cancers
Disease control OngoingThis study is for people with specific types of stomach cancer (mismatch repair deficient or Epstein-Barr virus positive) that can be surgically removed. It tests whether giving the immunotherapy drug pembrolizumab before and after standard chemotherapy and radiation can help pre…
Matched conditions: STAGE IIIB GASTRIC CANCER AJCC V7
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
New drug could boost Radiation's punch against stubborn gut cancers
Symptom relief OngoingThis early-phase trial tests an oral drug called ropidoxuridine (IPdR) in people with advanced gastrointestinal cancers that cannot be cured. The drug aims to make tumor cells more sensitive to radiation therapy. Researchers are studying the best dose and side effects in about 19…
Matched conditions: STAGE IIIB GASTRIC CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated May 06, 2026 16:01 UTC